12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress

Summary

The current trial will explore the safety of flibanserin in combination with Selective Serotonin Reuptake Inhibitors or Norepinephrine Serotonin Reuptake Inhibitors in a representative population of women with depressive and possible concurrent anxiety symptomatology.

Timeline

Start

2010-01

Primary completion

2011-01

Completion

2011-01

Outcome

Outcome not reported

Stopped: “Study terminated by Sponsor for administrative reasons prior to completion”

Drugs

Indications